Next Generation Sequencing Market Poised to Expand at a Robust Pace of $11.7 Billion Over 2028

 

Next Generation Sequencing Market Growth & Trends

The global next generation sequencing market size is anticipated to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.

Simplification in the NGS workflow coupled with the continued price reductions in instruments as well as reagents is attributed to the increasing adoption of this technology. The cost of sequencing the human genome has reduced from USD 100 million to less than USD 1,000 in less than two decades. Moreover, enhancement in the bioinformatics capabilities will lead to broadening of NGS adoption at the low- and high-throughput ends of the research market.

Several companies are engaged in the innovation of long-read sequencing technologies, which will augment the research as well as clinical application sets. The growing automation in the pre- & post-sequencing protocols, and data analysis is also driving the market. The utilization of novel platforms for the development of personalized medicine at a genetic level is also a significant factor, which is expected to boost the demand for NGS over the forecast period.

Request a free sample copy or view report summary: Next Generation Sequencing Market Report

Next Generation Sequencing Market Report Highlights

• The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology
• Companies like Myriad Genetics, Inc., through its myRisk product, offer genetic testing to identify people who may be at a higher risk of developing certain cancers in the future
• The high utility of NGS technology in the identification of coronavirus strains is expected to drive the infectious diseases segment with the fastest CAGR from 2021 to 2028
• Sequencing was the largest revenue-generating workflow segment in 2020 due to the introduction of novel, portable sequencers as a result of high competition
• In addition, owing to the expected increase in adoption and usage of WGS, sequencing is expected to witness the fastest CAGR over the forecast period
• The clinical research end-use segment is expected to register the fastest CAGR from 2021 to 2028. An increase in the utility of NGS technology and the support of key players for Covid-19 research is responsible for the segment growth
• For instance, in January 2021, to support the Covid-19 surveillance and research, Thermo Fisher Scientific extended its SARS-CoV-2 GlobalAccess Sequencing Program to offer additional units of Ion GeneStudio S5 sequencer and Ion Torrent Genexus System at a subsidized rate
• North America was the largest regional market owing to significant developments in the fields of companion diagnostics, personalized medicine, and NGS
• Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to the expansion of the molecular diagnostics field and high investments by global and local players in the Asian countries
• For instance, in January 2021, Crown Bioscience, Inc.; a U.S.-based platform technology innovator; launched NGS panel services at its Center of Translational Science in Suzhou, China

Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global next generation sequencing market on the basis of technology, application, workflow, end-use, and region:

NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• Reproductive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
  • Newborn Genetic Screening
  • Single Gene Analysis
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

 NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
  • Clonal Amplification
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Next Generation Sequencing Market

• Illumina
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Laboratory Service Market Soaring Demand Assures Motivated Revenue Share By 2028

 Clinical Laboratory Service Market Growth & Trends

The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. Growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to positively impact the market growth over the forecast period. For instance, according to the WHO, by 2030, cardiovascular diseases are estimated to cause approximately 23.6 million deaths, mainly from heart disease and stroke.

The COVID-19 pandemic, caused due to SARS-CoV-2, is affecting millions of people globally. According to WHO and CDC, the standard for laboratory diagnosis of COVID-19 is Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for samples collected from the respiratory tract. The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure are driving the market.

Furthermore, in May 2020, the Department of Health and Human Services (HHS) provided more than USD 200 million to clinics in rural areas of the U.S. to expedite COVID-19 testing. Such robust investments by government bodies to increase adoption of COVID-19 diagnostic kits by clinics are anticipated to boost segment growth. COVID-19 walk-up clinics in San Jose are another key initiative expected to positively impact segment growth.

In addition, advancements in laboratory testing technology through incremental and breakthrough developments are expected to serve this market as a high impact rendering driver. For instance, in March 2020, a Singapore-based med-tech company, Biolidics, launched a rapid test kit for COVID-19 and entered into a manufacturing agreement with a diagnostic kit manufacturer for mass production.

Automation in clinical settings has significantly improved the data management process in labs. Improving adoption rates of laboratory automation systems is expected to boost the market throughout the forecast period. Furthermore, database management tools, patient test records, and integrated workflow management systems have received significant consideration in the healthcare industry.

Request a free sample copy or view report summary: Clinical Laboratory Service Market Report

Clinical Laboratory Service Market Report Highlights

• In 2020, the clinical chemistry segment held majority of revenue share owing to presence of large number of tests due to increasing knowledge on clinical chemistry
• Stand-alone laboratories is expected to witness lucrative growth rate over the forecast period due to introduction of digital support systems to manage large databases and ability to provide better clinical laboratory services at a comparatively lower rate
• The bioanalytical and lab chemistry services segment dominated the market in 2020 owing to rising use of wide range of techniques and technology platforms to fulfill diagnostic needs
• In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to a growing awareness, increased government initiatives, and positive regulatory policies
• North America dominated the market in 2020 due to technological advancements and high awareness on medical standards

Clinical Laboratory Service Market Segmentation

Grand View Research has segmented the global clinical laboratory service market on the basis of test type, service provider, application, and region:

Clinical Laboratory Services Test Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Human & Tumor Genetics
• Clinical Chemistry
• Medical Microbiology & Cytology
• Other Esoteric Tests

Clinical Laboratory Services Provider Outlook (Revenue, USD Billion, 2017 - 2028)

• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Clinic-Based Laboratories

Clinical Laboratory Services Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Bioanalytical & Lab Chemistry
• Toxicology Testing
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Drug Discovery & Development Related Services
• Others

Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Laboratory Service Market

• Qiagen
• OPKO Health, Inc.
• Charles River Laboratories
• International, Inc
• Sonic Healthcare
• Almac Group
• Laboratory Corporation of America Holdings (LabCorp)
• DaVita, Inc.
• Viapath Group LLP
• Abbott
• SGS SA
• Quest Diagnostics, Inc.
• NeoGenomics Laboratories, Inc.
• Siemens Healthcare GmbH
• Fresenius Medical Care
• Cinven
• Arup Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-acne Cosmetics Market Booming Trends and Forecast Assessment for the Period 2021 to 2028

 Anti-acne Cosmetics Market Growth & Trends

The global anti-acne cosmetics market size is expected to reach USD 4.7 billion by 2028 registering a CAGR of 9.1%, according to a new report by Grand View Research, Inc. The high psychological burden associated with acne, especially among women, is expected to be the key growth-driving factor for the market. Moreover, the easy availability of various products to treat acne is anticipated to support the market growth. According to the American Academy of Dermatology, it is one of the common skin disorders in the U.S., affecting approximately 50 million individuals every year, with nearly 85% of individuals between the age group of 12 and 24 years having minor acne. Thus, a high prevalence of this skin disorder is also anticipated to fuel the product demand, thereby augmenting the market growth.

Furthermore, according to a study conducted by SkinStore, an average American woman uses nearly 16 skincare products per day and spends approximately USD 8 each day on facial cosmetics products. Such beauty regimes are also anticipated to propel market growth. According to the University of Limerick study, the negative social stigma associated with this skin disorder reduces the quality of life of individuals, increases their psychological distress, and causes physical problems, such as headaches, sleep disturbance, and gastrointestinal issues. This is also anticipated to increase the product demand over the coming years.

Request a free sample copy or view report summary: Anti-acne Cosmetics Market Report

Anti-acne Cosmetics Market Report Highlights

• The creams & lotions segment dominated the market in 2020 as the cream is the first line of therapy for all types of acne and it also provides skin moisturization
• The others product segment is expected to register the fastest CAGR over the forecast period due to the lightness of these products on the skin and compatibility with various skin types as compared to creams & lotions
• The women end-use segment held dominated share of the market in 2020 and is expected to grow at the fastest CAGR during the forecast period owing to a high prevalence of acne and other skin disorders
• Asia Pacific is anticipated to be the largest as well as the fastest-growing regional market from 2021 to 2028 due to increasing disposable income levels and growing population in developing countries

Anti-acne Cosmetics Market Segmentation

Grand View Research has segmented the global anti-acne cosmetics market on the basis of product type, end-use, and region:

Anti-acne Cosmetics Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Mask
• Creams & Lotions
• Cleansers & Toners
• Others

Anti-acne Cosmetics End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Women
• Men

Anti-acne Cosmetics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Anti-acne Cosmetics Market

• Neutrogena
• Clinique
• Murad
• Kose
• LaRochPosay
• Mentholatum
• L'Oréal
• Proactiv
• Vichy

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Central Nervous System Therapeutic Market is Thriving USD 205.0 Billion Revenue by 2028

 Central Nervous System Therapeutic Market Growth & Trends

The global central nervous system therapeutic market size is expected to reach USD 205.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. High unmet medical needs and government initiatives to reduce the disease burden are driving the market for central nervous system (CNS) therapeutic over the forecast period. According to WHO, the global economy loses due to depression and anxiety is more than USD 1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD 16 trillion in 2030.

The market holds strong future growth opportunities and major players are adopting different marketing strategies such as new product development, collaborations, geographic expansion, mergers and acquisitions, and new product approval, to strengthen their positions. In February 2020, Biogen announced the investment in Sangamo’s zinc finger platform to develop therapies for Alzheimer’s disease and other neurological diseases. Similarly, the company has an agreement with Ionis Pharmaceutical for the development of drug candidates applicable across a wide range of neurological diseases.

Presence of strong pipeline products by major pharmaceutical companies such as Biogen, H. Lundbeck A/S, Eli Lilly and Company, and others are expected to accelerate market growth over the forecast period. Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.

Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. The drug candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders. Apart from neurodegenerative diseases, migraine, schizophrenia, and epilepsy are the major CNS disease indications that have potential drug candidates in pipeline.

The cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing prevalence, high mortality rate, and rising demand for effective treatment are expected to fuel the growth of the market for CNS therapeutic. According to National Cancer Institute estimates, the number of new cases of CNS cancers was 23,890 whereas the number of deaths was 18,020 in the U.S. in 2020.

Pharmaceutical companies are adopting strategies such as product development, merger and acquisition, and collaboration to strengthen their position in market. For instance, Biogen has signed agreements with Ionis Pharmaceuticals, Atalanta Therapeutics, and Sangamo Therapeutics to develop novel therapeutics for the treatment of different disease indications of the central nervous system. Similarly, in January 2020, the CNS Pharmaceuticals has entered into a licensing agreement with MD Anderson Cancer Center to investigate WP1244, a designed DNA-binding agent to cross the blood-brain barriers for the potential treatment of brain cancers.

Request a free sample copy or view report summary: Central Nervous System Therapeutic Market Report

Central Nervous System Therapeutic Market Report Highlights

• The neurodegenerative diseases segment accounted for the largest revenue share of nearly 40.0% in 2020 and is anticipated to maintain its dominance over the forecast period
• Pipeline candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are anticipated to drive the neurodegenerative disorder segment from 2021 to 2028
• The CNS cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing demand for effective treatment is expected to drive the segment
• In Asia Pacific, the market is estimated to witness the fastest growth over the coming years owing to the increase in treatment rate and betterment of healthcare infrastructure in the region
• North America held a majority of share in 2020 due to high awareness level in the region and better reimbursement scenario

Central Nervous System Therapeutic Market Segmentation

Grand View Research has segmented the global central nervous system therapeutic market on the basis of disease and region:

CNS Therapeutic Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Neurovascular Diseases
• CNS Trauma
• Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
• Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
• Infectious Diseases
• CNS Cancer
• Others

CNS Therapeutic Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Central Nervous System Therapeutic Market

• Biogen
• Otsuka Pharmaceutical Co., Ltd.
• Eli Lilly and Company
• Merck & Co.
• Astra Zeneca
• Shire PLC
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson Services, Inc.
• Pfizer, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Rapid Medical Diagnostic Kits Market To Hold a High Potential for Growth by 2028

 Rapid Medical Diagnostic Kits Market Growth & Trends

The global rapid medical diagnostic kits market size is expected to reach USD 18.0 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. Rapid medical diagnostic kits enhance the speed of etiologic diagnosis of patients affected with chronic ailments. Moreover, speedy diagnosis is of paramount importance in individuals affected with infectious diseases. Thus, an increase in the number of manufacturers keen on exploring this space is driving the revenue in the market.

Key players are focusing on introducing novel medical supplies that require limited operational training, offer convenient usage, and ensure effective analysis. This is expected to propel the demand for rapid medical care among the industry’s target audience, which is inclusive of a general population affected with chronic diseases, coupled with the healthcare professionals determined to recommend an appropriate rapid medical evaluation.

The gradual shift toward point of care (POC) testing is also an important factor boosting the adoption of these test kits. Moreover, the recent pandemic outbreak of COVID-19 has piqued the interest of healthcare professionals in this industry space. High demand for portable testing kits in COVID-19 diagnostics is expected to make a significantly positive impact on the market expansion during the forecast period.

Novel rapid diagnostic tests are being developed that are expected to facilitate the prevention of infections along with antimicrobial stewardship. Newly developed tests are combined with Antimicrobial Stewardship (ASP) to optimize antimicrobial utilization as well as patient outcomes. Moreover, test kits with a broad scope of diagnosis and swift turnaround time are entering the space, offering lucrative opportunities for revenue growth.

For instance, in January 2021, Trinity Biotech’s Captia SARS-CoV-2 IgG ELISA rapid test secured the CE mark. The company has also stated that it has significant capacity for ELISA associated product manufacturewithin their current operations, aiding in speedy commercialization of this test kit across the globe.

Request a free sample copy or view report summary: Rapid Medical Diagnostic Kits Market Report

Rapid Medical Diagnostic Kits Market Report Highlights

• By product, over the counter (OTC) kits dominated the market in 2020 with a share of 54.3%. This is attributed to the routine adoption of OTC rapid diagnostic tests to ensure timely administration of an apt therapeutic intervention
• On the basis of technology, the lateral flow segment held the largest share of 35.1% in 2020. Convenient manufacturing protocols, coupled with low costs associated with the development, have led to the expansion of lateral flow assays into the rapid medical diagnostic market space
• The blood glucose testing application segment is estimated to expand at the fastest CAGR of 4.1% from 2021 to 2028. The imperative need for routine blood glucose monitoring in diabetic patients has contributed to the segment’s revenue generation capacity
• Based on end use, hospitals and clinics accounted for the largest revenue share in 2020 owing to the maximum adoption of rapid medical diagnostic kits
• Market entities are actively participating in the development of rapid medical test products to address the current pandemic outbreak of COVID-19, further intensifying the market competition

Rapid Medical Diagnostic Kits Market Segmentation

Grand View Research has segmented the global rapid medical diagnostic kits market on the basis of product, technology, application, end use, and region:

Rapid Medical Diagnostic Kits Product Outlook (Revenue, USD Million, 2017 - 2028)

• Over the Counter (OTC) Kits
• Professional Kits

Rapid Medical Diagnostic Kits Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Lateral Flow
• Agglutination
• Solid Phase
• Other Technologies

Rapid Medical Diagnostic Kits Application Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Glucose Testing
• Infectious Disease Testing
• Cardiometabolic Testing
• Pregnancy and Fertility Testing
• Fecal Occult Blood Testing
• Coagulation Testing
• Toxicology Testing
• Lipid Profile Testing
• Other Applications

Rapid Medical Diagnostic Kits End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals & Clinics
• Home Care
• Diagnostic Laboratories

Rapid Medical Diagnostic Kits Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Rapid Medical Diagnostic Kits Market

• ACON Laboratories, Inc.
• Abbott Laboratories
• Artron Laboratories Inc.
• Alfa Scientific Designs, Inc.
• Becton, Dickinson and Company
• BTNX, Inc.
• bioMérieux SA
• Cardinal Health
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Creative Diagnostics
• Meridian Bioscience, Inc.
• Hoffmann-La Roche AG
• McKesson Medical-Surgical, Inc
• Sight Diagnostics Ltd
• Trinity Biotech
• Zoetis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Precise Analysis on Business Overview, Product Scope And Ongoing Development

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermal Paper Market to Reach USD 6.03 Billion by 2028

 Thermal Paper Market Growth & Trends

The global thermal paper market size is expected to reach USD 6.03 billion by 2028 registering a CAGR of 5.2%, according to a new report by Grand View Research Inc. The growing product usage in tags & labels in the food & beverages and pharmaceutical industries is expected to drive the market growth over the forecast period. The rapid growth of the retailing industry in India, China, Indonesia, Brazil, UAE, and Saudi Arabia is boosting the use of retail transactions through PoS terminals. In addition, strict labeling norms in the food & beverages and pharmaceutical industries are further expected to boost the product demand.

The growing popularity of the gaming and casino industry across the world is also expected to provide a significant boost to the global market. Las Vegas, Singapore, and Macao are some of the most popular destinations that have gained prominence due to their gaming and casino industry. Increasing footfall at these places is expected to prove beneficial to the market growth. Companies in the Asia Pacific, particularly in Japan, have established their production units as well as strategic business channels in Europe and the U.S to cater to the buyers at the domestic level. Some of the manufacturers have formed partnerships with local roll converters for ensuring product supply to their consumers.

Request a free sample copy or view report summary: Thermal Paper Market Report

Thermal Paper Market Report Highlights

• In China, the tags & label segment is expected to grow at a CAGR 6.9% over the forecast period on account of growing product adoption in tags & labels in the food & beverages and retailing industries of the country
• In 2020, the revenue for the PoS application segment in the North America region stood at USD 709.6 million owing to the wide use of PoS machines at supermarkets, cafeterias, gas stations, and retail stores
• In Germany, the market is anticipated to reach USD 264.7 million by 2028 on account of increasing product usage in tags & labels for inventory management purposes in the regional manufacturing industry
• The PoS application segment in India is expected to register a CAGR of 11.4% over the forecast owing to the continued efforts by the Government of India to promote various types of cashless transaction modes
• With the growing restrictions of Bisphenol A-based products, manufacturers are progressively launching phenol-free thermal paper products in key markets

Thermal Paper Market Segmentation

Grand View Research has segmented the global thermal paper market on the basis of application and region:

Thermal Paper Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Point-of-Sale (PoS)
• Lottery & Gaming
• Tags & Labels
• Others

Thermal Paper Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Thermal Paper Market

• Ricoh Company, Ltd.
• Oji Holdings Corporation
• MPM Ltd.
• Appvion Incorporated
• Jujo Thermal Ltd.
• Lecta Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Home Infusion Therapy Market Expected To Trigger A Revenue To USD 44.7 Billion By 2028: Grand View Research, Inc.

 Home Infusion Therapy Market Growth & Trends

The global home infusion therapy market size is expected to reach USD 44.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biological products to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on market growth. According to a report by the WHO, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases that weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Request a free sample copy or view report summary: Home Infusion Therapy Market Report

Home Infusion Therapy Market Report Highlights

• By product, the infusion pumps segment held the largest revenue share in 2020 owing to the increasing use of delivery fluids, such as nutrients and medications
• The anti-infective application segment dominated the market in 2020 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals
• North America dominated the global market in 2020 owing to increasing demand for new technologies, along with advanced healthcare infrastructure
• The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Product Outlook (Revenue, USD Million, 2016 - 2028)

• Infusion Pumps
  • Elastomeric Pumps
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2016 - 2028)

• Anti-infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

List of Key Players of Home Infusion Therapy Market

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat (UnitedHealth Optum)
• PharMerica
• Fresenius Kabi
• ICU Medical, Inc.
• Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Drugs Market Size Is Expected To Reach USD 60.3 Billion by 2028

 Ophthalmic Drug Market Growth & Trends

The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050.

Moreover, due to COVID-19, it has become increasingly unsafe for individuals to touch their face several times a day, which is a known cause of transmission. Therefore, companies are developing long-acting, hands-free therapies to combat such challenges. For instance, in April 2020, Ocular Therapeutix, Inc. completed Phase III clinical trial to evaluate the safety and efficacy of DEXTENZA for allergic conjunctivitis. It is a hands-free therapy administered in the office setting as an intracanalicular insert. It is bioresorbable and designed to release the corticosteroid dexamethasone to the ocular surface, lasting 30 days. It is a one-time and long-acting therapy that can be useful during the COVID-19 crisis.

Investors are increasingly funding companies to support the clinical development of novel treatments for eye diseases thereby fueling the market growth. For instance, in February 2019, Oyster Point Pharma, Inc. received USD 93 million series B financing from Invus Opportunities, Flying L Partners, New Enterprise Associates (NEA), Versant Ventures, and Vida Ventures. The company’s product candidates include OC-01 and OC-02 in a Phase 2b clinical trial.

In addition, increasing development and approval of new laboratory methods is expected to boost the market growth. For instance, in July 2020, Quest Diagnostics received emergency Use Authorization (EUA) from the U.S. FDA for a laboratory technique that was developed for extracting viral RNA. This new technique was designed to expand the testing capacity of COVID-19 molecular tests.

Furthermore, key players in the market undertake various strategies to strengthen their product portfolios and offer diverse, technologically advanced, and innovative products. For instance, in September 2019, Alcon introduced iLUX Patient Care Kits to support practices in treating people with dry eyes in the U.S.

Request a free sample copy or view report summary: Ophthalmic Drug Market Report

Ophthalmic Drug Market Report Highlights

• In 2020, anti-VEGF agents dominated the market owing to high preference by ophthalmologists, enhanced tissue penetration, and rapid responsive rates
• Retinal disorders was the fastest-growing disease segment in 2020 owing to an increase in the prevalence of age-related macular degeneration and diabetic retinopathy, technological advancements, and rising strategic collaborations
• The topical route of administration dominated the market in 2020 due to the high patient compliance, non-invasiveness, and self-administrability
• The eye drops segment is estimated to witness the fastest growth over the forecast period due to impending launches of several ophthalmic solutions and suspensions in the near future and its direct drug delivery mechanism
• North America dominated the market and accounted for the largest revenue share in 2020 owing to the rising consumer awareness, high disease burden, technological advancements, and proactive government measures

Ophthalmic Drug Market Segmentation

Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region.

Ophthalmic Drugs Class Outlook (Revenue, USD Million, 2017 - 2028)

• Antiallergy
• Anti-VEGF Agents
• Anti-inflammatory
  • Nonsteroidal Drugs
  • Steroidal Drugs
• Antiglaucoma
• Others

Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Dry Eye
• Eye Allergy
• Glaucoma
• Eye Infection
• Retinal Disorders
  • Macular Degeneration
  • Diabetic Retinopathy
  • Others
• Uveitis
• Others

Ophthalmic Drugs Dosage Form Outlook (Revenue, USD Million, 2017 - 2028)

• Gels
• Eye Solutions
• Capsules & Tablets
• Eye Drops
• Ointments

Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2017 - 2028)

• Topical
• Local Ocular
  • Subconjunctival
  • Intravitreal
  • Retrobulbar
  • Intracameral
• Systemic

Ophthalmic Drugs Product Type Outlook (Revenue, USD Million, 2017 - 2028)

• Prescription Drugs
• OTC Drugs

Ophthalmic Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Ophthalmic Drugs Market

• Alcon
• Johnson & Johnson Services, Inc.
• Bausch Health
• Allergan
• Pfizer, Inc.
• Bayer AG
• Santen Pharmaceutical Co. Ltd.
• Genentech, Inc.
• Novartis AG
• Regeneron
• Merck & Co.
• Coherus Biosciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Health Market to Expand at a CAGR of 15.1% Through 2028: Grand View Research Inc.

 Digital Health Market Growth & Trends

The global digital health market size is expected to reach USD 295.4 billion by 2028 and is projected to expand at a CAGR of 15.1% over the forecast period, according to a new report by Grand View Research, Inc. Rising smartphone penetration & integration of advanced technologies, such as the internet of things (IoT) & artificial intelligence (AI), and increasing implementation of mHealth technologies for self-management of chronic diseases, such as diabetes, are some of the major factors driving the market. In addition, increasing demand for enhancing workflow efficiency in clinics, hospitals, and other healthcare centers is further boosting the demand for mHealth services thereby, aiding the market growth.

Moreover, ongoing technological advancements for developing advanced digital solutions coupled with a growing number of favorable initiatives by the government & private sectors are contributing to the overall market growth. For instance, as per the data published in 2017, researchers at the University of Illinois have developed a camera to improve the diagnostic features of smartphones. In 2020, the mHealth technology type segment accounted for the highest revenue share. A rise in the number of health apps has significantly contributed to the segment growth in recent years. As per the data published by the My Health Apps blog in May 2018, a total of 325,000 health, fitness, and medical apps were available in 2017.

Mobile operators are constantly leveraging mHealth technologies and solutions by supporting services, such as diagnosis, monitoring, and patient management. In addition, they are increasingly adopting strategies in the form of partnerships and agreements to enhance their product offerings, which, in turn, is contributing to the segment growth. For instance, in 2019, OneLife, a mobile medical software company, partnered with AT&T for the development of a health-tracking watch to monitor a patient’s heart rate, location, sleep, and movements. In 2020, the services component segment accounted for the highest revenue share.

System integration, training & education, maintenance & support, and consulting are among the few service offerings that are covered in this segment. Growing demand for continuous M2P data flows, to boost the efficiency of the medical systems, improve informed decision-making in real-time, and enhance security, is driving the segment growth. On the other hand, software is anticipated to register the fastest growth during the forecast period. The key factors that can be attributed to this growth are rising investments by the market participants to develop innovative connected solutions for the healthcare industry, technological advancements, and rising adoption of digital technologies & connected systems in the health centers.

Request a free sample copy or view report summary: Digital Health Market Report

Digital Health Market Report Highlights

• The mHealth technology segment dominated the global market in 2020 owing to the increasing penetration of smartphones and rising number of strategic alliances among mobile operators & mHealth startups.
• The services component segment accounted for the highest revenue share of the global market in 2020
• North America was the leading regional market in 2020 owing to rise in the geriatric population and awareness regarding health & fitness among consumers
• High internet and smartphones penetration along with growing usage of medical/health-related apps is one of the key factors responsible for the market growth in North America
• However, APAC is expected to register the fastest CAGR from 2021 to 2028 due to the rising usage of tablets, smartphones, and other mobile platforms
• The rising geriatric population in countries, such as India and China, and the growing burden of chronic conditions are further boosting the demand for mHealth technologies in the region

Digital Health Market Segmentation

Grand View Research, Inc. has segmented the global digital health market on the basis of technology, component, and region

Digital Health Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Tele-healthcare
  • Tele-care
    • Activity Monitoring
    • Remote medication Management
  • Tele-health
    • LTC Monitoring
    • Video Consultation
  • mHealth
    • Wearables
      • BP Monitors
      • Glucose Meters
      • Pulse Oximeters
      • Sleep Apnea Monitors
      • Neurological Monitors
      • Activity Trackers/Actigraphs
    • mHealth Apps
      • Medical Apps
      • Fitness Apps
    • Services
    • mHealth Services Market, By Type
      • Monitoring services
        • Independent Aging Solutions
        • Chronic Disease Management & Post-acute Care Services
      • Diagnosis Services
      • Healthcare Systems Strengthening Services
      • Others
    • mHealth Services Market, By Participants
      • Mobile Operators
      • Device Vendors
      • Content Players
      • Healthcare Providers
    • Healthcare Analytics
    • Digital Health Systems
      • EHR
      • E-prescribing Systems

Digital Health Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Hardware
• Services

Digital Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • UAE
  • South Africa
  • Saudi Arabia

List of Key Players of Digital Health Market

• Cerner Corporation
• Allscripts
• Apple, Inc.
• Telefónica S.A.
• Mckesson Corporation
• Epic Systems Corporation
• QSI Management, LLC
• AT&T
• Vodafone Group
• AirStrip Technologies
• Google, Inc.
• Samsung Electronics Co., Ltd.
• HiMS
• Orange
• Qualcomm Technologies, Inc.
• Softserve
• MQure
• Computer Programs and Systems, Inc.
• Vocera Communications
• IBM Corporation
• CISCO Systems, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Bone Graft And Substitutes Market to Witness Soaring Growth During 2021 – 2028

 Dental Bone Graft And Substitutes Market Growth & Trends

The global dental bone graft and substitutes market size is expected to reach USD 1.3 billion by 2028 registering a CAGR of 11.4%, according to a new report by Grand View Research, Inc. The increasing number of dental implant surgeries, the growing target population, and new product launches are the major growth propelling factors for the market. According to the Population Reference Bureau 2018 statistics, by 2050, from 13 countries to around 82 countries across the world are anticipated to have more than 20% of the geriatric population. Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of periodontal diseases.

Moreover, the rising adoption of synthetic bone grafts over autografts and allografts due to advantages, such as lesser chances of disease transmission, is further propelling the market growth. The growing medical tourism sector in developing countries is another factor driving the market. Countries, such as South Korea, India, and Turkey, are constantly gaining popularity in dental tourism due to cheaper costs and advanced treatment options. In addition, the rising number of periodontists and oral surgeons is boosting the market growth.

Request a free sample copy or view report summary: Dental Bone Graft And Substitutes Market Report

Dental Bone Graft And Substitutes Market Report Highlights

• The synthetic material type is expected to be the fastest-growing segment over the forecast period owing to its better acceptance and reduced risk of disease transmission
• Socket preservation application segment held the largest market in 2020 owing to the increasing number of dental implant surgeries and growing concerns regarding dental health
• The dental clinic end-use segment is expected to account for the maximum revenue share of the global market by 2028 due to the availability of surgeons and advanced treatment options offered in dental clinics
• Asia Pacific is expected to emerge as the fastest-growing regional market from 2021 to 2028 owing to the rapidly expanding medical tourism sector and growing disposable income
• Europe held the largest share in 2020 due to the increased number of dental implant surgeries in this region; however, North America is estimated to lead the market, in terms of revenue share, during the forecast period

Dental Bone Graft And Substitutes Market Segmentation

Grand View Research has segmented the global dental bone graft and substitutes market on the basis of material type, application, end-use, and region:

Dental Bone Graft And Substitutes Material Type Outlook (Revenue, USD Million, 2016 - 2028)

• Allograft
  • Demineralized Bone Matrix
  • Others
• Autograft
• Xenograft
• Synthetic

Dental Bone Graft And Substitutes Application Outlook (Revenue, USD Million, 2016 - 2028)

• Ridge Augmentation
• Sinus Lift
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Socket Preservation

Dental Bone Graft And Substitutes End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Dental Clinics

Dental Bone Graft And Substitutes Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Dental Bone Graft And Substitutes Market

• Institut Straumann AG
• Dentsply Sirona
• Medtronic PLC
• Zimmer Biomet
• RTI Surgical, Inc.
• Geistlich Pharma AG
• BioHorizons
• Orthogen
• Dentium Co., Ltd.
• LifeNet Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Medicine Market to Reflect Impressive Expansion During 2021 to 2028: Grand View Research Inc.

 Veterinary Medicine Market Growth & Trends

The global veterinary medicine market size is expected to reach USD 50.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. The companion animal segment is anticipated to demonstrate the fastest growth during the forecast period owing to the increasing prevalence of chronic diseases and rising demand for advanced treatment alternatives for canines suffering from chronic diseases.

COVID19 pandemic resulted in to regulatory changes which are anticipated to iron out the disruptions thereby increasing manufacturing and adoption of vet medicines in near future. The federal government has taken various relief measures which include new tax provisions, small business loans and unemployment insurance in order to respond to the pandemic and support the veterinarians. AVMA has also taken supportive measures to support small veterinary businesses or practices. In August 2020 USFDA stated that, 6 out of 32 animal drug companies who source their API from China could soon face shortages. Due to labor shortage, there is also reduced capacity to work on animal health activities such as vaccination, good biosecurity and prophylactic treatment. The manufacturing units are taking preventive measures for uninterrupted production of veterinary drugs.

Growing consumption of meat is fueling the demand for mandatory vaccination for animals, which results in the market growth. According to The World Counts, Denmark, the global meat production has increased 2-fold from 1988 to 2018. It also stated that meat consumption is estimated to range between 460 - 570 million tons by 2050. Such factors are expected to drive the growth of the market during the forecast period.

The market leaders are involved in strategic collaborations, regional expansion, and new product launch to sustain the competition. For instance, in Elanco acquired Bayer’s animal health division in August 2020 in an attempt to strengthen its R&D capabilities, eCommerce presence, and multiply its product portfolio. Additionally, in March 2020, Virbac signed an agreement with Pebble Labs for co-development and commercialization of products for disease prevention in aquatic animals.

Request a free sample copy or view report summary: Veterinary Medicine Market Report

Veterinary Medicine Market Report Highlights

• The production animal segment dominated the overall revenues share as of 2020 and is projected to show a CAGR of over 7.3% from 2021 to 2028. Increasing focus on food safety and sustainability by government healthcare organizations globally is contributing to market growth
• North America held a major market share as of 2020, due to the high prevalence of zoonotic diseases in this region. Moreover, reimbursement programs across the U.S. make this continent a major contributor to the market
• Europe held the second largest market share owing to the favorable government regulations such as the EU Veterinary Medicines Regulation and high number of insured pets in the Western European countries
• The industry participants are focusing on strategic collaborations, acquisitions, investing in new product segments, mergers, and new product launches to gain a competitive edge in the market
• Some of the leading players are expected to maintain their market position during the forecast period in terms of product penetration, regional presence, revenue, as well as strategic initiatives
• The biologics segment which includes vaccines and other such products is expected to exhibit the fastest growth over the forecast period owing to the increasing awareness regarding important of vaccination in animals
• The oral mode of administration is expected to grow at the fastest growth rate owing to the increasing incidence of chronic conditions in pets
• The reference laboratories held a considerable market share of about 9% in 2020 in the market as the laboratories enable testing of various infections, toxic agents, and different ailments in specimens obtained from pets
• Asia Pacific is anticipated to witness lucrative growth of around 8.0% owing to increasing adoption of pet animals, growing health concerns about the animals, and rising prevalence of diseases in animals

Veterinary Medicine Market Segmentation

Grand View Research has segmented the global veterinary medicine market on the basis of animal type, product, mode of delivery, end use, and region:

Veterinary Medicine Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Production
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
• Companion
  • Dogs
  • Cats
  • Horses
  • Others

Veterinary Medicine Product Outlook (Revenue, USD Million, 2016 - 2028)

• Biologics
  • Vaccine
    • Live attenuated vaccines
    • DNA Vaccines
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Others
  • Others
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Medicated Feed Additives

Veterinary Medicine Mode of Delivery Outlook (Revenue, USD Million, 2016 - 2028)

• Oral
• Parenteral
• Others (Topical, carrier)

Veterinary Medicine End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Reference Laboratories
• Point-of-care testing/In-house testing
• Veterinary Hospitals & Clinics
• Others

Veterinary Medicine Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Veterinary Medicine Market

• Merck Animal Health
• Ceva Sante Animale
• Vetoquinol S.A.
• Zoetis
• Boehringer Ingelheim GmbH
• Elanco
• Nutreco N.V.
• Virbac
• Kindred Biosciences, Inc.
• Biogenesis Bago
• Indian Immunologicals Ltd
• Neogen Corporation
• Hester Biosciences
• Philbro Animal Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Video Streaming Market to Mark a Highest CAGR of 21.0% Through 2028: Grand View Research Inc.

 

Video Streaming Market Growth & Trends

The global video streaming market size is expected to reach USD 223.98 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 21.0% from 2021 to 2028. Rising technological advancements such as the implementation of block-chain technology in video streaming and the use of artificial intelligence to improve video quality are expected to boost the demand for the market over the forecast period. Furthermore, the growing adoption of cloud-based video streaming solutions for increasing the reach of video content is directly influencing the growth. This trend is observed in numerous parts of the North American and Asia Pacific regions. The reasons attributing to the growth of the market are rapid digitalization, increasing use of mobiles and tablets, and the growing popularity of online video streaming.

The factors such as the rising demand for on-demand video and extensive growth of online video are the key growth drivers for the market. Also, the increasing demand for high-speed internet connectivity acts as an advantage for the market to grow over the forecast period. The growing acceptance of smartphones in combination with an extensive range of high-speed internet technologies such as 3G, 4G, and LTE has substantially led to the increasing use of video streaming. Also, the growing demand for devices that can support digital media is helping consumers to access media content anywhere across the world.

The market can be categorized, based on streaming type, into live video and non-linear video. The streaming of content via the internet and which can be displayed by the viewer in real-time can be defined as live video streaming. Further key findings from the report suggest that a live video segment is expected to portray the highest growth over the forecast period. In contrast, the non-linear video segment is expected to grow over the forecast period majorly due to the increasing demand for streaming of content via the internet and which can be viewed in real-time.

Further, the COVID-19 outbreak requires people to stay indoors and confine themselves at home for a prolonged period. This situation is expected to have a positive impact on video streaming services’ viewership and engagement. Moreover, it has resulted in an increased need for entertainment, thus resulting in higher consumption of video streaming services. The viewership of video streaming services has drastically risen across the globe, several video streaming platforms, including Netflix, Amazon Prime Video, YouTube, Disney+ have registered a spike in the viewership worldwide.

Request a free sample copy or view report summary: Video Streaming Market Report

Video Streaming Market Report Highlights

• The increasing usage of videos in corporate training and the impact of video streaming in the education sector are anticipated to drive the market growth
• The over-the-top (OTT) segment is expected to expand at the highest CAGR over the forecast period
• The Asia Pacific regional market is expected to have significant growth over the forecast period, majorly due to the increasing demand for high-speed internet connectivity and the growing demand for on-demand video streaming
• The key players in the market are Akamai Technologies; Amazon Web Services, Inc.; Apple Inc.; Cisco Systems, Inc.; Google; Kaltura, Inc.; Netflix; International Business Machine Corporation (IBM Cloud Video); Wowza Media Systems, LLC; AT&T Intellectual Property; and Hulu

Video Streaming Market Segmentation

Grand View Research has segmented the global video streaming market based on streaming type, solution, platform, service, revenue model, deployment type, user, and region:

Video Streaming Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Live Video Streaming
• Non-Linear Video Streaming

Video Streaming Solution Outlook (Revenue, USD Billion, 2017 - 2028)

• Internet Protocol TV
• Over-the-Top (OTT)
• Pay-TV

Video Streaming Platform Outlook (Revenue, USD Billion, 2017 - 2028)

• Gaming Consoles
• Laptops & Desktops
• Smartphones & Tablets
• Smart TV

Video Streaming Service Outlook (Revenue, USD Billion, 2017 - 2028)

• Consulting
• Managed Services
• Training & Support

Video Streaming Revenue Model Outlook (Revenue, USD Billion, 2017 - 2028)

• Advertising
• Rental
• Subscription

Video Streaming Deployment Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Cloud
• On-Premises

Video Streaming User Outlook (Revenue, USD Billion, 2017 - 2028)

• Enterprise
  • Corporate Communications
  • Knowledge Sharing & Collaborations
  • Marketing & Client Engagement
  • Training & Development
• Consumer
  • Real-Time Entertainment
  • Web Browsing & Advertising
  • Gaming
  • Social Networking
  • E-Learning

Video Streaming Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
• South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players of Video Streaming Market

• Akamai Technologies
• Amazon Web Services, Inc.
• Apple Inc.
• Cisco Systems, Inc.
• Google LLC
• Kaltura, Inc.
• Netflix, Inc.
• International Business Machine Corporation (IBM Cloud Video)
• Wowza Media Systems, LLC
• Hulu, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Data Collection And Labeling Market Size Is Expected To Reach $8.22 Billion by 2028

 

Data Collection And Labeling Market Growth & Trends

The global data collection and labeling market size is expected to reach USD 8.22 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 25.6% from 2021 to 2028. Data collection and labeling refer to the process of collecting datasets from online sources and other sources and labeling them based on their nature, data type, and feature. Data gathering and its annotation, combined with artificial intelligence (AI) technology, have created valuable growth opportunities in several verticals, such as gaming, social networking, and e-commerce. For instance, Twitter and Facebook, two major platforms in the world of social networking, have benefited from the image processing technology in terms of audience engagement as they have created a more connected experience by encouraging users to share images and tag their friends.

The advent of digital capturing devices, particularly cameras built into smartphones, has led to an exponential growth in the volume of digital content in the form of images and videos. A vast amount of visual and digital information is being captured and shared through several applications, websites, social networks, and other digital channels. Several businesses have leveraged this available online content to deliver smarter and better services to their customers, with the use of data annotation. For instance, Scale AI, Inc., the U.S.-based tech start-up, has provided valuable data labeling services to its autonomous driving customers, including Waymo LLC; Lyft, Inc.; Zoox; and Toyota Research Institute.

However, data cleaning remains a significant challenge involved in data labeling. Also, considering the time, complexity, and cost associated with the development of machine learning models, many companies may not have the resources who can produce acceptable and accurate results. Therefore, several companies are taking strategic initiatives to expand their business in the field of artificial intelligence-based data gathering. For instance, in July 2020, Microsoft acquired Orions Digital Systems, Inc., a U.S.-based data management solutions provider, to boost its Dynamics 365 Connected Store capabilities. This acquisition is anticipated to proliferate the use of computer vision and IoT sensors to help retailers better understand customer behavior and manage their physical spaces.

Request a free sample copy or view report summary: Data Collection And Labeling Market Report

Data Collection And Labeling Market Report Highlights

• Automated image organization offered by cloud-based applications and telecom companies is one of the most popular uses of data gathering that has improved the users’ experience and drawn the customers’ attraction towards this technology
• Several benefits, such as better security and automation of identification, are the factors encouraging the implementation of facial recognitionat significant public spaces or events

• The advent of large-scale cloud-hosted AI and machine learning platforms offered by tech giants, has led to the implementation of data annotation with multiple functions such as facial recognition, object recognition, and landmark detection
• The growing integration of digital image processing and mobile computing platforms in various applications such as digital shopping and document verification are propelling market growth

Data Collection And Labeling Market Segmentation

Grand View Research has segmented the global data collection and labeling market based on data type, vertical, and region:

Data Collection And Labeling Data Type Outlook (Revenue, USD Million, 2017 - 2028)

• Audio
• Image/ Video
• Text

Data Collection And Labeling Vertical Outlook (Revenue, USD Million, 2017 - 2028)

• IT
• Automotive
• Government
• Healthcare
• BFSI
• Retail & E-commerce
• Others

Data Collection And Labeling Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
• South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players of Data Collection And Labeling Market

• Reality AI
• Globalme Localization Inc.
• Global Technology Solutions
• Alegion
• Labelbox, Inc
• Dobility, Inc.
• Scale AI, Inc.
• Trilldata Technologies Pvt Ltd
• Appen Limited
• Playment Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.